A Non-Interventional Post-Authorization Safety Study of Pfizer-BioNTech Bivalent COVID-19 Vaccine in the United States
September 23, 2024
Authors:
Harvard Pilgrim Health Care Institute, RTI Health Solutions, CVS Health, Carelon Research, HealthPartners Institute, Humana HealthCare Research, Optum Epidemiology, Pfizer, Inc.
